Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Latterell Venture Partners

BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

How the slowly-progressing epigenetics field is moving away from cancer
BioCentury | Apr 7, 2017
Finance

Combo quest

Why NantKwest led Viracta’s B round
BioCentury | Apr 7, 2017
Financial News

Viracta completes venture financing

BioCentury | Apr 4, 2017
Financial News

Viracta raises $18.4M, strikes NantKwest deal

BioCentury | May 16, 2016
Financial News

Aptinyx completes venture financing

BioCentury | Sep 21, 2015
Financial News

Aptinyx completes venture financing

BioCentury | Mar 9, 2015
Finance

Column's creations

How The Column Group's long-term strategy yielded three wins
BioCentury | Feb 25, 2015
Company News

Shire exercises option to acquire Meritage

Items per page:
1 - 10 of 56